Co-Chairs:

Ilene Fennoy, MD and Ambika Ashraf, MD

Mission Statement:

Our mission is to affirm the ideology of the PES as a scientific community that fosters inclusion, acceptance, and support for every person independent of race, ethnicity, gender, sexual orientation, or religion. Towards this end, our focus is to:

  1. Recognize implicit and explicit bias in healthcare in Pediatric Endocrinology, and address related healthcare disparities that affect our patients and families, through research, quality improvement, health delivery science, education, and outreach efforts.
  2. Foster equity and diversity and provide an environment of equality and mentorship for all trainees, fellows, and faculty in Pediatric Endocrinology.

Goals:

Our task force goals for the coming year are to increase awareness in our society’s membership of implicit and explicit bias in medicine in general and Pediatric Endocrinology specifically, and the contribution of said biases to health care disparities as well as to career development of minority physicians. We also aim to start to amass resources to help us address and ameliorate these biases and resulting disparities. We will contribute regularly to the newsletter, develop a needs assessment survey of our society, and will plan to offer periodic education for the PES membership.

Beyond the Prescription: Navigating Systemic Barriers  

Ambika Ashraf MD, University of Alabama at Birmingham; Ilene Fennoy MD, Columbia University Medical Center 

As December brings a time of reflection and family, it also casts a sharp light on the immense pressures our patients and their families navigate. Beyond managing complex endocrine conditions, many are struggling with systemic barriers, from insurance gaps to transportation hurdles, that are often amplified at the end of the year. As pediatric endocrinologists, our advocacy in these moments is not adjacent to our work; it is central to our mission. 

Consider the (de-identified) story of 'David,' a 14-year-old with type 1 diabetes. His family’s insurance plan is changing on January 1st. Our clinic staff, already stretched thin, spends hours on prior authorizations for his insulin pump and CGM. The family calls, worried, because their new high-deductible plan means the first insulin refill of the year will cost them over $800—a choice between their child's health and paying their heating bill. 

This experience is not an isolated anecdote. We see it in the family that cannot afford the co-pay for genetic testing for a child with a suspected rare endocrine disorder, leaving them in a diagnostic limbo. We see it in adolescents with type 2 diabetes whose insurance denies coverage for a CGM, removing a critical tool for managing their condition. We see it in the enormous co-payments required for vital medications like SGLT2 inhibitors, placing proven cardiovascular and renal protection out of reach for many. 

We see these systemic failures when insurance plans categorically refuse to cover new weight loss medications for children with obesity, or even for those with type 1 diabetes and concurrent obesity, despite clear evidence of their benefits. We see it in the family from a rural community, driving three hours each way for an appointment, missing a full day of wages and school. 

These are not individual problems; they are systemic gaps. Insurance limitations, geographic isolation, and unaffordable drug pricing are barriers that disproportionately affect low-income, immigrant, and minority populations, perpetuating generational cycles of poor health outcomes. 

As 2025 comes to a close, let this reflection be our call to action for the new year. Our expertise as clinicians and researchers positions us to lead. 

  1. Advocate in Our Clinics: Let's be as intentional about screening for social determinants of health as we are about monitoring A1c or bone age. When we identify a family struggling, we must connect them with social workers, patient assistance programs, and community resources. This is a critical clinical intervention. 
  1. Advocate in Our Institutions: We must challenge our hospital leadership and insurance partners to simplify access. This includes pushing for streamlined prior authorization processes for essential medications and technology and advocating for expanded telehealth access to bridge geographic divides. 
  1. Advocate in Our Communities: We must use our collective voice. Our patient stories, backed by data, are the most powerful tools we have to demand policy change. Whether writing an op-ed or joining a PES or Endocrine Society "Hill Day", we can advocate for policies that cap insulin costs, protect access to gender-affirming care, and fund vital pediatric research. 

This December, as we reflect on the past year, let us recommit to this essential work. The health of our patients depends not only on our clinical skill but on our courage to challenge the systems that create and perpetuate disparity. Let's make the coming year one that not only recognizes these systems that negatively impact on our patients, but one in which we engage in meaningful, collective action to resolve them. 

Archive - Monthly notable dates/events

March 28, 2024: State of the Art: EDI

Title: Disparities in Diabetes Technology: An Evidence-based Roadmap to Equity

Description:

In this webinar, we will discuss multi-factorial drivers of disparities in pediatric type 1 diabetes with a specific focus on the role of diabetes technology utilization. We will cover evidence-based solutions to address disparities relevant to clinicians and researchers alike. We will also discuss emerging technology disparities and system-level solutions to mitigate new disparities.

Learning Objectives

  1. Recognize diabetes technology as a modifiable risk factor in type 1 diabetes and identify populations at risk of inequitable diabetes care.
  2. Illustrate how diabetes technology is underutilized in minoritized populations and is subject to inequity.
  3. Recognize ways to identify and mitigate inequities in diabetes technology use.

Speaker: Ananta Addala, DO, MPH, Assistant Professor of Pediatrics at Stanford University

View Recording

 

Podcast Club

The Immortal Life of Henrietta Lacks

Tuesday, October 14, 2025, 8:00pm Eastern time

We’re excited to announce that we will be discussing The Immortal Life of Henrietta Lacks and its related podcast.

The Immortal Life of Henrietta Lacks

Join us for robust discussion: https://zoom.us/meeting/register/fyPzlN_JSh-h1ydgUzTuaw

The Immortal Life of Henrietta Lacks

How one woman, without her knowing, may have saved us all.

 

 

 

 

Additional EDI Resources of Interest

PES Addressing Health Disparities Research Grant

Each year we solicit applications for the Addressing Health Disparities Research Grant. The Purpose of this grant is to support the development of research and education in equity, diversity and inclusion involving pediatric endocrinology that will enhance pediatric endocrinologists’ ability to understand the needs of their patients and colleagues and deliver more equitable and inclusive education and services to a diverse population of trainees, colleagues, and patients. The current open call will close December 16, 2024!

Click here for more information

PES Cookbook Initiative

On behalf of The Health Systems Disparity Committee Committee of The Pediatric Endocrine Society, we are very pleased to inform the PES membership of a new initiative: The “PES Community Cooking Initiative.”

Each day is a new opportunity for us to eat healthily. We are creating a PES Cultural Cookbook, a collection of culturally diverse recipes. Please share your favorite recipes here https://pedsendo.org/pes-cooking-initiative/ it can vary from a family recipe from your ancestors or one you have invented yourself.  We believe this initiative will help us understand our history, diversity, interactions, cultures, and traditions.  Please include carbohydrate counting information with your recipe.

Click here for recipes.

GET INVOLVED!

Email Info@pedsendo.org if you are interested in getting involved!